RNAi Therapeutics Market Set to Record USD 8.80 billion by 2033 - Key Leaders - Benitec Biopharma, Thermo Fisher Scientific Inc and Sirnaomics Inc, Dicerna Pharmaceuticals, Silence Therapeutics

AI Briefing

• – RNAi Therapeutics Market to reach USD 8.80 billion by 2033, growing at a CAGR of 24.1% from 2023 to 2033, key players include Benitec Biopharma, Thermo Fisher Scientific Inc and Sirnaomics Inc, Dicerna Pharmaceuticals and Silence Therapeutics.